Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ERSP Review Of Claims Lights Fire Under Smoking-Cessation Marketer

This article was originally published in The Tan Sheet

Executive Summary

Final Smoke Inc. voluntarily modifies claims for its smoking-cessation system, including a dietary supplement and homeopathic detoxification liquid, in conjunction with an Electronic Retailing Self-Regulation Program review

Final Smoke Inc. voluntarily modifies claims for its smoking-cessation system, including a dietary supplement and homeopathic detoxification liquid, in conjunction with an Electronic Retailing Self-Regulation Program review.

ERSP says Aug. 25 that the revisions made by the Chino, Calif.-based direct marketer present "a clearer and considerably more accurate message regarding the performance of" the Final Smoke system to consumers.

An anonymous challenger brought Final Smoke's claims - which included "Eliminates the desire to smoke," "Flushes the body of nicotine" and "Never desire another cigarette" - to the attention of the Council of Better Business Bureaus forum.

The challenger emphasized the "heightened" need for accurate claims and sufficient substantiation for a smoking-cessation product, given the serious health risks associated with smoking, ERSP says. Smoking cessation is a potential priority area for FDA as it begins regulation of tobacco products.

Final Smoke maintained to ERSP that it "does not attempt to market a 'miracle pill'" and the success of the system depends on psychological cues and educational information in its supporting materials. The marketer said it would eliminate claims of "immediate" relief and "emphasize in future advertising that it is the collective components of Final Smoke" that make it unique and effective.

ERSP found the herbal ingredient Lobelia inflata in Final Smoke does have "homeopathic provings" as a mechanism of nicotine withdrawal and meets manufacturing guidelines. However, it encouraged the company to clearly state that the substance is homeopathic.

In a statement, Final Smoke thanks ERSP "for its role in maintaining the integrity of the direct-response industry through self-regulation."

ERSP reviewed marketing materials for another smoking-cessation program, CigArrest , in 2006. It found the marketer had adequate substantiation for claims made for its homeopathic formula but advised changes to more extreme claims relating to the speed of associated smoking cessation (1 'The Tan Sheet' Feb. 27, 2006, In Brief).

- Dan Schiff ( 2 [email protected] )

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS103272

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel